SC 13G/A: BICYCLE THERAPEUTICS PLC
Ticker: BCYC · Form: SC 13G/A · Filed: Nov 13, 2024 · CIK: 1761612
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by BICYCLE THERAPEUTICS PLC.
Risk Assessment
Risk Level: low
Filing Stats: 1,112 words · 4 min read · ~4 pages · Grade level 11 · Accepted 2024-11-13 21:30:38
Filing Documents
- ef20038551_sc13ga.htm (SC 13G/A) — 78KB
- 0001140361-24-046592.txt ( ) — 80KB
(a)
Item 1(a). Name of Issuer: Bicycle Therapeutics plc (the "Issuer")
(b)
Item 1(b). Address of Issuer's Principal Executive Offices: Blocks A & B, Portway Building, Granta Park Great Abington, Cambridge, United Kingdom CB21 6GS
(a)
Item 2(a). Name of Person Filing: Jefferies LLC Jefferies Financial Group Inc. (each a "Reporting Person" and collectively, the "Reporting Persons")
(b)
Item 2(b). Address of Principal Business Office or, if None, Residence: 520 Madison Ave., New York, NY 10022
(c)
Item 2(c). Citizenship: The responses of the Reporting Persons to Row 4 in each of their respective cover pages are incorporated herein by reference.
(d)
Item 2(d). Title and Class of Securities: Ordinary Shares, nominal value 0.01 per share ("Ordinary Shares").
(e)
Item 2(e). CUSIP Number: 088786108 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act (b) Bank as defined in Section 3(a)(6) of the Exchange Act (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act (d) Investment company registered under Section 8 of the Investment Company Act (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E) (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F) (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (j) A non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J) (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K) If filing as a non-U.S. institution in accordance with Rule 13d–1(b)(1)(ii)(J), please specify the type of institution: 4 Item 4. (a)-(c) The responses of the Reporting Persons to Rows 5, 6, 7, 8, 9 and 11 in each of their respective cover pages which relate to the beneficial ownership of Common Stock, as of September 30, 2024, are incorporated herein by reference. As of September 30, 2024, the Reporting Persons beneficially owned 0 Ordinary Shares of the Issuer. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the Common Stock, check the following . Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Re